openPR Logo
Press release

Bioactive Peptides Market to Reach US$ 4.11 Billion by 2032, Growing at 5.4% CAGR on Rising Therapeutic and Functional Nutrition Demand | DataM Intelligence

12-22-2025 01:18 PM CET | Food & Beverage

Press release from: DataM Intelligence 4 Market Research LLP

Bioactive Peptides Market

Bioactive Peptides Market

According to DataM Intelligence, the global Bioactive Peptides Market is valued at US$ 2.70 billion in 2024 and is expected to reach US$ 4.11 billion by 2032, growing at a CAGR of 5.4% during the forecast period 2025-2032. The market growth is primarily driven by expanding applications of bioactive peptides in pharmaceuticals, nutraceuticals, functional foods, and clinical nutrition, along with increasing consumer focus on preventive healthcare and targeted therapeutic solutions.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/bioactive-peptides-market?jd

North America (Largest Market) - Key Industry Developments
North America leads the bioactive peptides market, supported by strong pharmaceutical research infrastructure, high healthcare spending, and early adoption of functional and therapeutic nutrition products.
✅ November 2025: Pharmaceutical companies in the U.S. expanded clinical research programs focused on antihypertensive and immunomodulatory peptides for chronic disease management.
✅ October 2025: Nutraceutical brands increased product launches incorporating bioactive peptides in capsule and powder formats, targeting cardiovascular and metabolic health.
✅ September 2025: Regulatory clarity and favorable labeling frameworks supported wider adoption of peptide-based functional ingredients in dietary supplements.

Asia-Pacific (Fastest Growing Market) - Key Industry Developments
Asia-Pacific is the fastest-growing region, driven by rising health awareness, expanding pharmaceutical manufacturing, and growing demand for functional foods.
✅ November 2025: Manufacturers in China, Japan, and South Korea expanded production capacities for marine- and plant-based bioactive peptides to meet domestic and export demand.
✅ October 2025: Functional food and beverage companies in Asia-Pacific increased adoption of antioxidant and antimicrobial peptides in fortified products.
✅ September 2025: Growing investments in biotechnology and peptide extraction technologies accelerated innovation in nutraceutical and therapeutic applications.

Key Mergers and Acquisitions (2025):
✅ October 2025: A global ingredient supplier acquired a peptide technology startup to strengthen its bioactive peptide portfolio and expand pharmaceutical-grade production capabilities.
✅ September 2025: A leading nutrition company completed a strategic acquisition of a marine peptide manufacturer to enhance its presence in high-growth Asia-Pacific markets.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=bioactive-peptides-market
(Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis
-By Source: Animal-Based and Marine Peptides Lead Demand
Animal-based peptides hold a significant share due to well-established production processes and clinical validation, while marine-derived peptides are gaining traction for their high bioavailability and antioxidant properties. Plant-based peptides are also witnessing steady growth aligned with clean-label and vegan nutrition trends.

-By Form: Powder Segment Dominates Market Share
Powdered bioactive peptides dominate due to ease of formulation, stability, and wide use across supplements, functional foods, and pharmaceuticals. Capsules/tablets and liquid formats are gaining popularity in targeted therapeutic and consumer nutrition products.

-By Function: Antihypertensive and Antioxidant Peptides Drive Growth
Antihypertensive and antioxidant peptides represent key functional segments, supported by rising prevalence of cardiovascular disorders and oxidative stress-related conditions. Immunomodulatory and anti-inflammatory peptides are emerging as high-growth categories.

Regional Insights
North America holds the largest share of the Bioactive Peptides Market, driven by advanced pharmaceutical research, high nutraceutical consumption, and strong regulatory frameworks. Asia-Pacific is the fastest-growing region, supported by expanding functional food markets, rising healthcare awareness, and increasing biotechnology investments. Europe continues steady growth due to strong demand for clean-label and functional nutrition products.

Growth Drivers:
1. Rising Demand for Therapeutic and Preventive Healthcare Solutions: Bioactive peptides offer targeted health benefits.
2. Expansion of Functional Foods and Nutraceuticals: Growing consumer preference for scientifically backed nutrition fuels demand.
3. Pharmaceutical Applications of Peptides: Increasing use in chronic disease and metabolic disorder treatments.
4. Advances in Peptide Extraction and Formulation Technologies: Improved bioavailability and stability enhance adoption.
5. Growing Health Awareness and Ageing Population: Preventive nutrition trends drive long-term market growth.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioactive-peptides-market?jd

Key Players:
The major players in the Bioactive Peptides Market include Archer Daniels Midland Company (ADM), DSM, BASF SE, Glanbia plc, Rousselot S.A.S., Arla Foods Ingredients Group P/S, Kerry Group plc, Fonterra Co-operative Group Limited, Angel Yeast Co., Ltd., and Seagarden.

Key Highlights (Top 5 Key Players):
1. ADM leverages strong agricultural sourcing and ingredient innovation for bioactive peptide applications.
2. DSM focuses on clinically supported peptide ingredients for health and nutrition markets.
3. BASF SE supports pharmaceutical and functional food sectors with advanced peptide chemistry expertise.
4. Glanbia plc specializes in high-quality nutritional peptides for sports and clinical nutrition.
5. Kerry Group plc integrates bioactive peptides into functional food and beverage solutions.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply-Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioactive Peptides Market to Reach US$ 4.11 Billion by 2032, Growing at 5.4% CAGR on Rising Therapeutic and Functional Nutrition Demand | DataM Intelligence here

News-ID: 4325050 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Mobile Water Treatment Market set for steady growth at a CAGR of 7.2%, led by North America 67% global market share.
Mobile Water Treatment Market set for steady growth at a CAGR of 7.2%, led by No …
The Mobile Water Treatment Market size, shares, recent trends, competitive intelligence, and future market outlook. The market is estimated to grow at a CAGR of 7.2% during the forecast period 2024-2031. Demand from Municipal, Power Industry, Mining, Construction, Chemicals, Pharmaceutical, Refineries, Electronics, Steel Manufacturing Industry in North America is growing. Competitive rivalry intensifies with WesTech Engineering, Inc, Veolia, Lenntech B.V and others operating in the market. Get a Free Sample PDF
Stretch Wrap Machines Market Poised to Reach US$ 1.11 Billion by 2031, Driven by Rising Automation and Packaging Efficiency Demand | DataM Intelligence
Stretch Wrap Machines Market Poised to Reach US$ 1.11 Billion by 2031, Driven by …
According to DataM Intelligence, the Global Stretch Wrap Machines Market reached US$ 751.7 million in 2023 and is expected to reach US$ 1,105.2 million by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. Market growth is driven by increasing demand for automated and semi-automated packaging solutions, rising emphasis on load stability and product safety during transportation, and growing adoption across food & beverage, pharmaceuticals, automotive, and
Oncology Biosimilars Market to Reach US$ 30.83 Billion by 2033 at 18.6% CAGR; Patent Expiries and Cost Pressures Drive Adoption - Key Players: Amgen, Pfizer, Celltrion
Oncology Biosimilars Market to Reach US$ 30.83 Billion by 2033 at 18.6% CAGR; Pa …
The Global Oncology Biosimilars Market reached US$ 6.76 billion in 2024, up from US$ 5.77 billion in 2023, and is expected to reach US$ 30.83 billion by 2033, growing at a CAGR of 18.6% during the forecast period 2025-2033. The market is expanding rapidly as healthcare systems seek cost-effective alternatives to high-priced biologic cancer therapies, helping improve patient access and reduce overall oncology treatment costs. Market growth is primarily driven by
Future of Refractories Market Growth to Reach (CAGR Of 3.6%) by 2031: North America's Led by Share 20.24 | Most Leading Companies - HarbisonWalker International, Resco Products, IFGL Refractories Ltd, Magnezit Group, Mineral Technologies Inc
Future of Refractories Market Growth to Reach (CAGR Of 3.6%) by 2031: North Amer …
Refractories Market to grow at a CAGR Of 3.6% during the forecast period 2024-2031 Request Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/refractories-market?kb United States: Recent Industry Developments ✅ November 2025: Major refractory producers expanded high-alumina and monolithic refractory capacity to support steel and non-ferrous metal production. ✅ October 2025: Increased investments in energy-efficient and low-carbon refractories aligned with decarbonization goals in U.S. manufacturing. ✅ September 2025: Adoption of

All 5 Releases


More Releases for Peptide

ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support. ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established